SPY301.29-1.68 -0.55%
DIA252.47-1.88 -0.74%
IXIC9,358.35-10.64 -0.11%

bluebird bio Q1 EPS $(3.640) Beats $(4.010) Estimate

bluebird bio (NASDAQ:BLUE) reported quarterly losses of $(3.640) per share which beat the analyst consensus estimate of $(4.010) by 9.23 percent. This is a 21.74 percent decrease over losses of $(2.990) per share from

Benzinga · 05/11/2020 11:25

bluebird bio (NASDAQ:BLUE) reported quarterly losses of $(3.640) per share which beat the analyst consensus estimate of $(4.010) by 9.23 percent. This is a 21.74 percent decrease over losses of $(2.990) per share from the same period last year.